Position history for UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC's holdings in IOVANCE BIOTHERAPEUTICS INC
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC holds 474,099 shares of IOVA (IOVANCE BIOTHERAPEUTICS INC), worth $1.7M as of 2026-Q1. The position was increased (+0.9% shares). IOVA represents 0.0% of UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC's portfolio.
Current Value
$1.7M
Current Shares
474,099
Total Value Change
-$14.3M
Total Shares Change
-1.5M
Other major holders of IOVA: BANQUE PICTET & CIE SA, BNP PARIBAS FINANCIAL MARKETS
Increased |
| 474,099 |
+0.9% |
| $1.7M |
| 0.0% |
| $3.74 |
26 |
| 2025-Q4 | Decreased | 469,706 | -2.5% | $1.3M | 0.0% | $2.77 | 0 |
| 2025-Q3 | Decreased | 481,781 | -26.7% | $1M | 0.0% | $2.23 | 0 |
| 2025-Q2 | Decreased | 657,209 | -88.6% | $1.1M | 0.0% | $1.69 | 0 |
| 2025-Q1 | Increased | 5.8M | +202.8% | $19.2M | 0.0% | $3.56 | 46 |
| 2024-Q4 | Decreased | 1.9M | -2.0% | $14.1M | 0.0% | $7.17 | 0 |
| 2024-Q3 | Decreased | 1.9M | -2.4% | $18.3M | 0.0% | $9.61 | 0 |
| 2024-Q2 | Increased | 2M | +1009.0% | $16M | 0.0% | $8.02 | 45 |